ArticleJournal of ophthalmic inflammation and infection2026
Eosinophilic esophagitis is associated with increased risk of allergic conjunctivitis: a multicenter cohort study.
Article in Journal of ophthalmic inflammation and infection, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEosinophilic esophagitis (EoE) is a chronic, Th2-driven inflammatory esophageal disease frequently associated with atopic disorders. However, ocular comorbidities in EoE, particularly allergic conjunctivitis, have not been well characterized. In this study, we compare the incidence of ocular outcomes, with a focus on allergic conjunctivitis, between patients with EoE and matched controls with gastroesophageal reflux disease with esophagitis (GERD-E).
methodsWe conducted a retrospective, propensity score-matched cohort study using the TriNetX Global Collaborative Network, including 23,488 patients with EoE and 23,488 matched GERD-E controls. Eligible patients had at least one ophthalmology encounter ≥ 30 days after the index diagnosis. The primary outcome was allergic conjunctivitis; secondary outcomes included dry eye syndrome, keratoconjunctivitis sicca, blepharitis, meibomian gland dysfunction, and uveitis. Kaplan-Meier analyses, log-rank tests, and Cox proportional hazards models were used to estimate hazard ratios (HRs) over a 3-year follow-up period.
resultsEoE was associated with a higher 3-year risk of allergic conjunctivitis compared with GERD-E (HR 1.42; 95% CI [1.20,- 1.69]; p < 0.001). No significant differences were observed for dry eye syndrome, keratoconjunctivitis sicca, blepharitis, meibomian gland dysfunction, or uveitis. Positive and negative control outcomes supported internal validity.
conclusionsPatients with EoE have an elevated risk of allergic conjunctivitis compared with GERD-E, consistent with the systemic Th2 inflammatory profile of EoE. Other ocular comorbidities were not significantly increased. These findings highlight the importance of multidisciplinary, allergy-aware care in patients with EoE.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.